KETAMIR-2, a new molecular entity and novel ketamine analog.

Front Pharmacol · 2025 · PMC12231361 · PMID 40626306

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Mice treated with Ketamir-2 also showed a trend of more time spent in the center, however it was not statistically significant.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.